Patent Yard Sign in
Canadian application, no grantCanada

Compositions and methods for the diagnosis and treatment of herpes simplex virus infection

CA 2481087 A1 · Owner: Corixa Corporation · Inventors: Day, Craig H.; Hosken, Nancy A.; Parsons, Joseph M.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Compounds and methods for the diagnosis and treatment of HSV infection are provided. The compounds comprise polypeptides that contain at least one antigenic portion of an HSV polypeptide and DNA sequences encoding such polypeptides. Pharmaceutical compositions and vaccines comprising such polypeptides or DNA sequences are also provided together with antibodies , directed against such polypeptides. Diagnostic kits are also provided comprising such polypeptides and/or DNA sequences and a suitable detection reagent for the detection of HSV infection in patients and in biological samples.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed April 9, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 9, 2023.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 9, 2025.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledApril 9, 2003
GrantedNo grant recorded
Term endedApril 9, 2023
Patent numberCA 2481087 A1
Classification (IPC)A61K39/12 +2 more

Timeline

Timeline From CIPO dates

2004200620082010201220142016201820202022Application filedApril 9, 2003Term endedApril 9, 2023

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.